Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome

BGP-15 is a new insulin sensitizer drug candidate, which was developed by Hungarian researchers. In recent years, numerous research groups have studied its beneficial effects. It is effective in the treatment of insulin resistance and it has protective effects in Duchenne muscular dystrophy, diastol...

Descripción completa

Detalles Bibliográficos
Autores principales: Pető, Ágota, Kósa, Dóra, Fehér, Pálma, Ujhelyi, Zoltán, Sinka, Dávid, Vecsernyés, Miklós, Szilvássy, Zoltán, Juhász, Béla, Csanádi, Zoltán, Vígh, László, Bácskay, Ildikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024383/
https://www.ncbi.nlm.nih.gov/pubmed/31968693
http://dx.doi.org/10.3390/molecules25020429